Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03205436 · ClinicalTrials.gov registry record · NA
Affinity Prospective Diabetic Foot Trial Crossover Group
A NA study, sponsored by Organogenesis.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03205436 is a NA study that has completed, run by Organogenesis. The registered enrollment target is 20 participants.
The verdict
NCT03205436, a NA study, has completed, sponsored by Organogenesis.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is an extension of the randomized controlled trial NT-DFU-AFF-01. Subjects that were randomized to the Standard of Care group will be able to crossover to the NT-DFU-AFF-02 trial and receive Affinity fHSAM if certain criteria are met.
Interventions
- OTHER Affinity human amniotic membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03205436
The ClinicalTrials.gov registry entry for NCT03205436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organogenesis, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Affinity human amniotic membrane is the first listed.
NCT03205436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03205436 about?
NCT03205436 is a clinical study titled "Affinity Prospective Diabetic Foot Trial Crossover Group". This study is an extension of the randomized controlled trial NT-DFU-AFF-01. Subjects that were randomized to the Standard of Care group will be able to crossover to the NT-DFU-AFF-02 trial and receive Affinity fHSAM if certain criteria are met.
What is the current status of trial NCT03205436?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-01. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT03205436?
The interventions under investigation include: Affinity human amniotic membrane (OTHER).
Who is sponsoring clinical trial NCT03205436?
This trial is sponsored by Organogenesis, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.